Tuberculosis

MEASURE Evaluation achievements in support of the STOP TB Strategy include supporting global standards for tuberculosis monitoring and evaluation; capacity building and technical assistance; development of TB tools and supporting country TB information systems; and evaluation/research.

Although tuberculosis (TB) is curable, it has devastating consequences on public health worldwide, second only to HIV in the number of deaths from infectious disease. In the most recent statistics available, the World Health Organization (WHO) has estimated that 10.4 million people developed TB in 2015 and 1.8 million died of TB-related causes. Over 95 percent of TB deaths occur in low- and middle-income countries.  

Co-infection with HIV is also an issue, which makes testing for HIV critical to identify those individuals. In 2015, 35 percent of HIV deaths were due to TB. In Africa, where the burden of HIV-associated TB is the highest, the rate of  notified TB patients who also had a documented HIV test result stood at 81 percent, up from only half in 2013. Another issue is that in 2015 almost a half million people globally developed multidrug-resistant TB, yet only 1 in 5 of them were enrolled in treatment.

The WHO has a goal for an end to the global TB epidemic by 2035. In order to reach that goal, efforts must be intensified and successes sustained through sufficient funding. To help determine the impact of these interventions, MEASURE Evaluation assists to develop monitoring and evaluation (M&E) standards and tools for national TB program surveillance systems to generate high-quality data for monitoring impact. As data from direct measurements within countries expand and improve, the estimates of TB burden can be refined to better track progress toward meeting the new targets set by WHO. 

MEASURE Evaluation also supports USAID’s commitment to the implementation of its STOP TB Strategy to reduce morbidity and mortality associated with TB, and in particular to strengthen TB information systems. MEASURE Evaluation partners with WHO, USAID, and additional key stakeholders, such as the Global Fund and others, to develop and implement global standards and tools, as well as to strengthen technical and organizational M&E capacity of TB programs, ministries of health and local NGOs at national and sub-national levels in various countries.

MEASURE Evaluation applies a systems approach to this important work by:

  • Strengthening TB information systems, one of the key components of the directly observed treatment, short course (DOTS) approach;
  • Establishing and supporting global standards for TB M&E;
  • Building both technical and organizational M&E capacity of TB organizations;
  • Improving the quality, coverage, timeliness, and sustainability of TB information systems;
  • Conducting TB evaluation/research. 

Related Content

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs

M&E of Tuberculosis Control Programs Module

Three Interlinked Patient Monitoring Systems for HIV care/ART, MCH/PMTCT and TB/HIV

Strengthening Tuberculosis Control in Ukraine: Impact Evaluation Baseline Survey, Ukraine 2014 

Infectious Diseases Tools

Filed under: